These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Plasma neutrophil gelatinase-associated lipocalin as a marker for the prediction of worsening renal function in children hospitalized for acute heart failure. Elsharawy S; Raslan L; Morsy S; Hassan B; Khalifa N Saudi J Kidney Dis Transpl; 2016 Jan; 27(1):49-54. PubMed ID: 26787566 [TBL] [Abstract][Full Text] [Related]
3. Admission plasma neutrophil gelatinase associated lipocalin (NGAL) predicts worsening renal function during hospitalization and post discharge outcome in patients with acute heart failure. Palazzuoli A; Ruocco G; Beltrami M; Franci B; Pellegrini M; Lucani B; Nuti R; Ronco C Acute Card Care; 2014 Sep; 16(3):93-101. PubMed ID: 24836558 [TBL] [Abstract][Full Text] [Related]
4. Comparison between admission natriuretic peptides, NGAL and sST2 testing for the prediction of worsening renal function in patients with acutely decompensated heart failure. De Berardinis B; Gaggin HK; Magrini L; Belcher A; Zancla B; Femia A; Simon M; Motiwala S; Bhardwaj A; Parry BA; Nagurney JT; Coudriou C; Legrand M; Sadoune M; Di Somma S; Januzzi JL; Clin Chem Lab Med; 2015 Mar; 53(4):613-21. PubMed ID: 25473804 [TBL] [Abstract][Full Text] [Related]
5. Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure. Palazzuoli A; Ruocco G; Pellegrini M; De Gori C; Del Castillo G; Franci B; Nuti R; Ronco C Am J Cardiol; 2015 Jul; 116(1):104-11. PubMed ID: 25943992 [TBL] [Abstract][Full Text] [Related]
6. Plasma Neutrophil Gelatinase-Associated Lipocalin and Predicting Clinically Relevant Worsening Renal Function in Acute Heart Failure. Damman K; Valente MAE; van Veldhuisen DJ; Cleland JGF; O'Connor CM; Metra M; Ponikowski P; Cotter G; Davison B; Givertz MM; Bloomfield DM; Hillege HL; Voors AA Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28698481 [TBL] [Abstract][Full Text] [Related]
7. Relation of systemic and urinary neutrophil gelatinase-associated lipocalin levels to different aspects of impaired renal function in patients with acute decompensated heart failure. Shrestha K; Shao Z; Singh D; Dupont M; Tang WH Am J Cardiol; 2012 Nov; 110(9):1329-35. PubMed ID: 22835414 [TBL] [Abstract][Full Text] [Related]
11. Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial. Maisel AS; Mueller C; Fitzgerald R; Brikhan R; Hiestand BC; Iqbal N; Clopton P; van Veldhuisen DJ Eur J Heart Fail; 2011 Aug; 13(8):846-51. PubMed ID: 21791540 [TBL] [Abstract][Full Text] [Related]
12. Elevated urinary neutrophil gelatinase-associated lipocalcin after acute heart failure treatment is associated with worsening renal function and adverse events. Collins SP; Hart KW; Lindsell CJ; Fermann GJ; Weintraub NL; Miller KF; Roll SN; Sperling MI; Sawyer DB; Storrow AB Eur J Heart Fail; 2012 Sep; 14(9):1020-9. PubMed ID: 22733980 [TBL] [Abstract][Full Text] [Related]
13. Neutrophil gelatinase-associated lipocalin in the diagnosis of type 1 cardio-renal syndrome in the general ward. Alvelos M; Pimentel R; Pinho E; Gomes A; Lourenço P; Teles MJ; Almeida P; Guimarães JT; Bettencourt P Clin J Am Soc Nephrol; 2011 Mar; 6(3):476-81. PubMed ID: 21115620 [TBL] [Abstract][Full Text] [Related]
14. Plasma neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury in acute heart failure. Breidthardt T; Socrates T; Drexler B; Noveanu M; Heinisch C; Arenja N; Klima T; Züsli C; Reichlin T; Potocki M; Twerenbold R; Steiger J; Mueller C Crit Care; 2012 Jan; 16(1):R2. PubMed ID: 22226205 [TBL] [Abstract][Full Text] [Related]
15. Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock. Wheeler DS; Devarajan P; Ma Q; Harmon K; Monaco M; Cvijanovich N; Wong HR Crit Care Med; 2008 Apr; 36(4):1297-303. PubMed ID: 18379258 [TBL] [Abstract][Full Text] [Related]
17. Plasma neutrophil gelatinase-associated lipocalin as early biomarker for acute kidney injury in burn patients. Hong DY; Lee JH; Park SO; Baek KJ; Lee KR J Burn Care Res; 2013; 34(6):e326-32. PubMed ID: 23511281 [TBL] [Abstract][Full Text] [Related]
18. The diagnostic accuracy of plasma neutrophil gelatinase-associated lipocalin in the prediction of acute kidney injury in emergency department patients with suspected sepsis. Shapiro NI; Trzeciak S; Hollander JE; Birkhahn R; Otero R; Osborn TM; Moretti E; Nguyen HB; Gunnerson K; Milzman D; Gaieski DF; Goyal M; Cairns CB; Kupfer K; Lee SW; Rivers EP Ann Emerg Med; 2010 Jul; 56(1):52-59.e1. PubMed ID: 20363526 [TBL] [Abstract][Full Text] [Related]
19. Neutrophil gelatinase-associated lipocalin at ICU admission predicts for acute kidney injury in adult patients. de Geus HR; Bakker J; Lesaffre EM; le Noble JL Am J Respir Crit Care Med; 2011 Apr; 183(7):907-14. PubMed ID: 20935115 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of plasma neutrophil gelatinase-associated lipocalin for mortality in patients with heart failure. van Deursen VM; Damman K; Voors AA; van der Wal MH; Jaarsma T; van Veldhuisen DJ; Hillege HL Circ Heart Fail; 2014 Jan; 7(1):35-42. PubMed ID: 24347663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]